AYTU BIOPHARMA, INC Restricted Cash and Cash Equivalents
AYTU BIOPHARMA, INC (AYTU) had Restricted Cash and Cash Equivalents of $38.16 million as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2020-11-12
- 2020-09-30: Restricted Cash and Cash Equivalents $38.16M.
- 2020-06-30: Restricted Cash and Cash Equivalents $48.33M.
- 2020-03-31: Restricted Cash and Cash Equivalents $62.52M.
- 2019-12-31: Restricted Cash and Cash Equivalents $5.51M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2020-09-30 | $38.16M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $48.33M 10-Q · filed 2020-11-12 |
| 2020-03-31 | $62.52M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $5.51M 10-Q · filed 2020-02-14 |
| 2019-09-30 | $7.26M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $11.29M 10-Q · filed 2020-11-12 |
| 2019-03-31 | $14.75M 10-Q · filed 2020-05-15 |
| 2018-12-31 | $17.91M 10-Q · filed 2020-02-14 |
| 2018-09-30 | $4.06M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $7.11M 10-K · filed 2020-10-06 |
| 2018-03-31 | $12.08M 10-Q · filed 2019-05-14 |
| 2017-12-31 | $3.98M 10-Q · filed 2019-05-14 |
| 2017-09-30 | $7.10M 10-Q · filed 2018-11-07 |
| 2017-06-30 | $877.54K 10-K · filed 2019-09-26 |
| 2016-06-30 | $8.05M 10-K · filed 2018-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |